Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Sio Gene Therapies (SIOX) Short Interest Ratio & Short Volume

Sio Gene Therapies logo

Sio Gene Therapies Short Interest Data

Sio Gene Therapies (SIOX) has a short interest of 140,900 shares, representing 0.26% of the float (the number of shares available for trading by the public). This marks a 97.34% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 0 shares to cover all short positions.

Current Short Interest
140,900 shares
Previous Short Interest
71,400 shares
Change Vs. Previous Month
+97.34%
Dollar Volume Sold Short
$57,853.54
Short Interest Ratio
0.2 Days to Cover
Last Record Date
March 15, 2023
Outstanding Shares
69,560,000 shares
Float Size
53,450,000 shares
Short Percent of Float
0.26%
Today's Trading Volume
40,403 shares
Average Trading Volume
0 shares
Today's Volume Vs. Average
Short Selling Sio Gene Therapies?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Sio Gene Therapies and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SIOX Short Interest Over Time

SIOX Days to Cover Over Time

SIOX Percentage of Float Shorted Over Time

Sio Gene Therapies Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/2023140,900 shares $57,853.54 +97.3%0.3%0.2 $0.41
2/28/202371,400 shares $29,338.26 -26.2%0.1%0.1 $0.41
2/15/202396,700 shares $39,763.04 -73.7%0.2%0.1 $0.41
1/31/2023367,000 shares $163,682.00 +99.0%0.7%0.5 $0.45
1/15/2023184,400 shares $82,426.80 +9.6%0.4%0.3 $0.45
12/30/2022168,200 shares $73,167.00 +5.3%0.3%0.3 $0.44
12/15/2022159,700 shares $65,301.33 +19.8%0.3%0.3 $0.41
11/30/2022133,300 shares $41,043.07 -34.6%0.3%0.5 $0.31
11/15/2022203,800 shares $62,770.40 +53.5%0.4%0.9 $0.31
10/31/2022132,800 shares $38,910.40 -60.5%0.3%0.6 $0.29
10/15/2022335,800 shares $103,090.60 +7.4%0.6%1.5 $0.31
9/30/2022312,700 shares $87,556.00 +74.2%0.6%1.5 $0.28
9/15/2022179,500 shares $61,012.05 +7.6%0.3%0.6 $0.34
8/31/2022166,800 shares $55,878.00 -15.2%0.3%0.4 $0.34
8/15/2022196,600 shares $68,082.58 +22.7%0.4%0.3 $0.35
7/31/2022160,300 shares $54,870.69 -45.1%0.3%0.2 $0.34
7/15/2022291,700 shares $109,416.67 +5.2%0.6%0.3 $0.38
6/30/2022277,400 shares $99,919.48 +15.7%0.5%0.3 $0.36
6/15/2022239,800 shares $86,328.00 +33.4%0.5%0.3 $0.36
5/31/2022179,800 shares $60,233.00 -12.2%0.3%0.3 $0.34
5/15/2022204,700 shares $57,316.00 -37.2%0.4%0.4 $0.28
4/30/2022326,100 shares $91,568.88 -5.3%0.6%0.6 $0.28
4/15/2022344,300 shares $210,023.00 -8.9%0.6%0.7 $0.61
3/31/2022378,100 shares $253,327.00 -18.7%0.7%0.8 $0.67
3/15/2022465,000 shares $261,702.00 -33.9%0.9%0.9 $0.56
2/28/2022703,600 shares $471,412.00 +26.6%1.3%1.2 $0.67
2/15/2022555,800 shares $390,505.08 -37.8%1.0%0.9 $0.70
1/31/2022893,100 shares $1.04 million +56.0%1.7%1.3 $1.17
1/15/2022572,700 shares $687,240.00 -1.8%2.0%0.9 $1.20
12/31/2021583,000 shares $752,070.00 -5.5%2.0%0.5 $1.29
12/15/2021617,200 shares $851,736.00 -9.2%2.1%0.5 $1.38
11/30/2021679,900 shares $1.08 million -29.7%2.3%0.6 $1.59
11/15/2021967,300 shares $1.81 million -23.8%3.3%0.8 $1.87
10/29/20211,270,000 shares $2.43 million +45.5%4.3%1.1 $1.91
10/15/2021872,600 shares $1.90 million -19.2%3.0%0.8 $2.18
9/30/20211,080,000 shares $2.34 million -27.0%3.7%1.6 $2.17
9/15/20211,480,000 shares $3.27 million -18.2%5.0%2.4 $2.21
8/31/20211,810,000 shares $3.91 million +33.1%6.3%2.5 $2.16
8/13/20211,360,000 shares $2.76 million +8.8%4.7%2.1 $2.03
7/30/20211,250,000 shares $2.55 million -1.6%4.3%1.9 $2.04
3..2..1.. AI 2.0 ignition (don’t sleep on this) (Ad)

I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
7/15/20211,270,000 shares $2.96 million No Change4.3%1.9 $2.33
6/30/20211,270,000 shares $3.47 million -2.3%4.3%2 $2.73
6/15/20211,300,000 shares $3.39 million -6.5%4.4%1.8 $2.61
5/28/20211,390,000 shares $3.17 million +3.0%5.1%2.3 $2.28
5/14/20211,350,000 shares $2.79 million +8.9%4.9%1.5 $2.07
4/30/20211,240,000 shares $3.35 million +54.0%4.5%1 $2.70
4/15/2021805,200 shares $2.05 million +6.1%2.9%0.6 $2.54
3/31/2021759,200 shares $1.88 million +49.2%2.8%0.5 $2.47
3/15/2021508,700 shares $1.43 million +19.1%1.9%0.3 $2.82
2/26/2021427,300 shares $1.13 million -35.3%1.7%0.2 $2.64
2/12/2021660,500 shares $2.19 million -29.4%2.7%0.3 $3.32
1/29/2021935,900 shares $2.40 million +4.0%3.8%0.4 $2.56
1/15/2021900,300 shares $2.60 million No Change3.6%0.4 $2.89
10/30/20201,920,000 shares $7.01 million +33.3%8.6%1.1 $3.65
10/15/20201,440,000 shares $5.14 million +173.5%6.4%1 $3.57
9/30/2020526,500 shares $2.43 million +98.1%2.4%0.4 $4.62
9/15/2020265,800 shares $967,512.00 -1.9%1.2%0.4 $3.64
8/31/2020270,800 shares $804,276.00 +5.4%1.2%0.8 $2.97
8/14/2020257,000 shares $786,420.00 -17.6%1.2%0.8 $3.06
7/31/2020311,700 shares $931,983.00 +4.4%1.4%1.3 $2.99
7/15/2020298,500 shares $1.04 million +17.7%1.4%1.3 $3.50
6/30/2020253,600 shares $730,368.00 -3.8%1.2%1.5 $2.88
6/15/2020263,700 shares $883,395.00 -10.2%1.2%1.6 $3.35
5/29/2020293,600 shares $971,816.00 +5.4%1.4%1.8 $3.31
5/15/2020278,700 shares $883,479.00 -3.8%1.4%1.4 $3.17

SIOX Short Interest - Frequently Asked Questions

What is Sio Gene Therapies' current short interest?

Short interest is the volume of Sio Gene Therapies shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 140,900 shares of SIOX short. 0.26% of Sio Gene Therapies' shares are currently sold short. Learn More on Sio Gene Therapies' current short interest.

What is a good short interest percentage for Sio Gene Therapies?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.26% of Sio Gene Therapies' floating shares are currently sold short.

Is Sio Gene Therapies' short interest increasing or decreasing?

Sio Gene Therapies saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 140,900 shares, an increase of 97.3% from the previous total of 71,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Sio Gene Therapies' float size?

Sio Gene Therapies currently has issued a total of 0 shares. Some of Sio Gene Therapies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sio Gene Therapies currently has a public float of 53,450,000 shares.

How does Sio Gene Therapies' short interest compare to its competitors?

0.26% of Sio Gene Therapies' shares are currently sold short. Here is how the short interest of companies compare to Sio Gene Therapies: Eli Lilly and Company (0.76%), Johnson & Johnson (0.87%), AbbVie Inc. (0.96%), Novo Nordisk A/S (0.43%), Novartis AG (0.24%), Abbott Laboratories (1.26%), AstraZeneca PLC (0.20%), Merck & Co., Inc. (1.67%), Sanofi (0.16%), Pfizer Inc. (1.90%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($3.66 billion), Occidental Petroleum Co. ($2.62 billion), Coinbase Global, Inc. ($2.38 billion), T. Rowe Price Group, Inc. ($2.13 billion), Verisk Analytics, Inc. ($2.08 billion), Snowflake Inc. ($1.95 billion), Paramount Global ($1.78 billion), Etsy, Inc. ($1.60 billion), Teck Resources Limited ($1.51 billion), and Voya Financial, Inc. ($1.49 billion). View all of the most shorted stocks.

What does it mean to sell short Sio Gene Therapies stock?

Short selling SIOX is an investing strategy that aims to generate trading profit from Sio Gene Therapies as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Sio Gene Therapies?

A short squeeze for Sio Gene Therapies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SIOX, which in turn drives the price of the stock up even further.

How often is Sio Gene Therapies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SIOX, twice per month. The most recent reporting period available is March, 15 2023.




This page (NASDAQ:SIOX) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners